Ubs Asset Management Americas Inc Vera Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 61,574 shares of VERA stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,574
Previous 55,080
11.79%
Holding current value
$2.31 Million
Previous $1.99 Million
36.55%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
183Shares Held
55.6MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$161 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$147 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$125 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$111 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$105 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.01B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...